(Updated - August 6, 2024 6:12 AM EDT)

BofA Securities analyst Jason Gerberry upgraded Axsome Therapeutics (NASDAQ: AXSM) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE